Biofac A/S

Public limited companyCVR 62550511KastrupActive

Biofac A/S is a public limited company, based in Kastrup, active in manufacture of basic pharmaceutical products, founded in 1934. The company went from a profit in 2024 to a loss of DKK 3.8m in 2025. Measured by gross profit, it ranks no. 3 of 14 companies in the industry in the database. With 83 employees, the company is about 4 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 73.6m+12.2% vs. 2024
Net profit−DKK 3.8m−1,235.5% vs. 2024
EquityDKK 10.8m−25.9% vs. 2024
Employees83latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 12% (2024 → 2025), to DKK 73.6m.
  • Net profit went from a profit of DKK 333k to a loss of DKK 3.8m (2024 → 2025).
  • Equity fell 26% (2024 → 2025), to DKK 10.8m.

Employees

  • 1 more employees than a year earlier: 83 (07/2026) against 82 (07/2025).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 10m−DKK 5mDKK 0DKK 5mDKK 10mDKK 15mDKK 20m202020212022202320242025
EquityNet profit
Financial figures for Biofac A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit23,38728,82420,28937,26865,66573,647+12.2%
Operating profit (EBIT)−4,204366−6,2796,4655,180−436−108.4%
Profit before tax−5,376−1,418−7,6042,063430−4,623−1,174.2%
Net profit−4,193−1,135−5,9531,610333−3,776−1,235.5%
Total assets164,460161,491142,566156,736161,331151,156−6.3%
Equity19,73218,59712,64414,25414,58610,810−25.9%
Liabilities140,407137,348125,609137,785142,018136,897−3.6%
Cash and cash equivalents667522,12712978249−74.5%
Average number of employees767375–7477+4.1%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60mDKK 70m202020212022202320242025
Gross profitMedian, the industry (14 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Low equity ratio

    Equity makes up 7% of total assets in 2025.

    How is this calculated?

    Equity ÷ total assets is below 10% in the latest annual report. Banks, insurers and some industries naturally have a low ratio.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Biofac A/S
Financial yearPeriodPublishedFigures forDocuments
202501/07/2024 – 30/06/202515/12/2025The companyPDF not statedXBRL
202401/07/2023 – 30/06/202412/12/2024The companyPDFXBRL
202301/07/2022 – 30/06/202321/12/2023The companyPDFXBRL
202201/07/2021 – 30/06/202205/12/2022The companyPDFXBRL
202101/07/2020 – 30/06/202108/12/2021The companyPDFXBRL
202001/07/2019 – 30/06/202007/11/2020The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02040608008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

14 companies in the database

Comparison with the other companies in manufacture of basic pharmaceutical products based on the latest financial year.

Gross profitDKK 73.6mNo. 3 of 14
Better than 85% of the companies in the industry
EquityDKK 10.8mNo. 7 of 14
Better than 54% of the companies in the industry
Number of employees83No. 4 of 14
Better than 77% of the companies in the industry

Industry median: gross profit DKK 13.9m, net profit DKK 80,789, equity DKK 10.1m, 19 employees.

DKK 100kDKK 749kDKK 5.6mDKK 42mDKK 161mHere
Distribution of gross profit for 14 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 1,072of 4,412
Better than 76%
No. 2,806of 4,466
Better than 37%
Companies that are at least 30 years old10,276 companies in the comparison
No. 1,087of 10,152
Better than 89%
No. 4,590of 10,275
Better than 55%
All companies of type A/S18,025 companies in the comparison
No. 2,055of 17,786
Better than 88%
No. 8,446of 18,024
Better than 53%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of basic pharmaceutical products
Gross profit
  1. Biofac A/SDKK 73.6m
  2. Xellia Pharmaceuticals ApSDKK 314.9m
  3. Glycom Manufacturing A/SDKK 226.3m
Net profit
  1. Biofac A/S−DKK 3.8m
  2. Xellia Pharmaceuticals ApSDKK 213.7m
  3. Glycom Manufacturing A/SDKK 69.2m
Equity
  1. Biofac A/SDKK 10.8m
  2. Xellia Pharmaceuticals ApSDKK 404.6m
  3. Glycom Manufacturing A/SDKK 577.7m

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • H&P Rørvig Holding A/S100%
Biofac A/S

Management

4 active registrations

Executive management

Executive management at Biofac A/S
NameRoleAppointed
Peter RørvigDirector17/11/1934

Board of directors

Board of directors at Biofac A/S
NameRoleAppointed
Peter RørvigBoard member17/11/1934
Niels Ulrik HeineBoard member18/02/1998
Helle RørvigBoard member30/11/2005
Former management (6)
Former management at Biofac A/S
NameRoleAppointedResigned
Erik Vilhelm BalslevBoard member17/11/193418/02/1998
Lore RørvigBoard member17/11/193422/11/1988
Ludmilla Tamara Dorothea ThiesenBoard member17/11/193422/11/1988
Niels Otto ThiesenBoard member17/11/193408/09/2006
Niels Otto ThiesenDirector17/11/193422/11/1988
Svend BlankholmBoard member23/11/200413/02/2020

Signing rule: Selskabet tegnes af 1 direktør eller af 1 bestyrelsesmedlem.

Address and production units

2 active production units

Englandsvej 350
2770 Kastrup

Tårnby Municipality · Postcode 2770

Other companies at the address (2)

Production units
Production unitAddressEmployeesP number
BIOFAC A/SEnglandsvej 350, 2770 Kastrup541003149167
BIOFAC A/SEjbyvej 44, 4623 Lille Skensved271003149179

Purpose

Selskabets formål er at drive industri og handel eller dermed beslægtet virksomhed efter bestyrelsens skøn såvel i ind- som i udland

The purpose is quoted from the register in Danish.

Changes year by year

31 registered events
20251 changeaccounts 1
  • Annual report for 2025 published
20241 changeaccounts 1
  • Annual report for 2024 published
20231 changeaccounts 1
  • Annual report for 2023 published
20221 changeaccounts 1
  • Annual report for 2022 published
20213 changesaccounts 1 · address 2
  • Annual report for 2021 published
  • Moved to Englandsvej 350-356, 2770 Kastrup
  • Moved to Englandsvej 350-356, 2770 Kastrup
20202 changesaccounts 1 · management 1
  • Annual report for 2020 published
  • Svend Blankholm stepped down as board member
20171 changeaddress 1
  • Moved to Englandsvej 350-356, 2770 Kastrup
20061 changemanagement 1
  • Niels Otto Thiesen stepped down as board member
20052 changesmanagement 1 · ownership 1
  • Helle Rørvig appointed board member
  • H&P Rørvig Holding A/S registered as owner (100%)
20041 changemanagement 1
  • Svend Blankholm appointed board member
19983 changescapital 1 · management 2
  • Share capital changed from 500,000 DKK to 1,000,000 DKK
  • Niels Ulrik Heine appointed board member
  • Erik Vilhelm Balslev stepped down as board member
19961 changecapital 1
  • Share capital changed from 400,000 DKK to 500,000 DKK
19911 changemerger 1
  • Merger registered in CVR
19883 changesmanagement 3
  • Niels Otto Thiesen stepped down as director
  • Ludmilla Tamara Dorothea Thiesen stepped down as board member
  • Lore Rørvig stepped down as board member
19871 changemerger 1
  • Merger registered in CVR
19348 changesfounded 1 · management 7
  • Registered as BIOFAC A/S
  • Niels Otto Thiesen appointed board member
  • Niels Otto Thiesen appointed director
  • Erik Vilhelm Balslev appointed board member
  • Peter Rørvig appointed board member
  • Peter Rørvig appointed director
  • Ludmilla Tamara Dorothea Thiesen appointed board member
  • Lore Rørvig appointed board member

Related companies

Same industry in Tårnby

See all →

Same people in management

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction